![Adrian Gottschalk](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Adrian Gottschalk
Algemeen Directeur bij
FOGHORN THERAPEUTICS INC.
Vermogen: 2 M $ op 31-05-2026
Profiel
Adrian Gottschalk is President, Chief Executive Officer & Director at Foghorn Therapeutics, Inc. since 2017.
Formerly, Mr. Gottschalk was SVP & Head-Neurodegeneration Therapeutic Area at Biogen, Inc. from 2015 to 2017.
Education includes an undergraduate degree from Texas A&M University in 1997, an MBA from MIT Sloan School of Management in 2003, and a graduate degree from Harvard Medical School in 2004.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 20-04-2026 | 511.704 ( 0,87% ) | 2 M $ | 31-05-2026 |
Actieve functies van Adrian Gottschalk
| Bedrijven | Functie | Begin |
|---|---|---|
| FOGHORN THERAPEUTICS INC. | Algemeen Directeur | 01-05-2017 |
Eerdere bekende functies van Adrian Gottschalk
| Bedrijven | Functie | Einde |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01-05-2017 |
Opleiding van Adrian Gottschalk
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
92
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Texas A&M University
 Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Foghorn Therapeutics, Inc.
 Foghorn Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops novel drugs to treat cancer and other serious medical disorders | Health Technology |
